Meeting ReportEndocrine/Neuroendocrine Cancers

Can absorbed doses by organs and tumors after PRRT be predicted from the pre-therapeutic 68Ga-DOTATATE PET/CT study?

CHICHEPORTICHE ALEXANDRE, Moshe Sason, Yodphat Krausz, JEREMY GODEFROY, Simona Grozinsky-Glasberg, Kira Oleinikov, David J. Gross and Simona Ben-Haim
Journal of Nuclear Medicine August 2022, 63 (supplement 2) 2213;

Article Information

vol. 63 no. supplement 2 2213
Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online August 8, 2022.
Copyright & Usage 
© 2022

Author Information

  1. CHICHEPORTICHE ALEXANDRE1,
  2. Moshe Sason2,
  3. Yodphat Krausz1,
  4. JEREMY GODEFROY,
  5. Simona Grozinsky-Glasberg,
  6. Kira Oleinikov,
  7. David J. Gross and
  8. Simona Ben-Haim3
  1. 1Department of Nuclear Medicine & Biophysics, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Israel
  2. 2Hadassah
  3. 3Hadassah Medical Organization and Hebrew University of Jerusalem

Statistics from Altmetric.com

Cited By...

Article usage

Article usage: July 2022 to April 2025

AbstractFullPdf
Jul 2022200
Aug 20221100
Sep 2022800
Oct 20221500
Nov 20222000
Dec 2022900
Jan 2023500
Feb 2023600
Mar 20231200
Apr 2023600
May 2023800
Jun 20231500
Jul 2023500
Aug 2023400
Sep 2023400
Oct 2023600
Nov 2023100
Dec 2023600
Jan 2024700
Mar 2024800
Apr 20243700
May 20241000
Jun 20243000
Jul 202411000
Aug 20249400
Sep 20242300
Oct 2024900
Nov 2024500
Dec 2024200
Feb 20251100
Mar 2025700
Apr 2025500
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 63, Issue supplement 2
August 1, 2022
Article Alerts
Email Article
Citation Tools
Bookmark this article

Jump to section